What’s Driving India’s Biologicals Boom

The market value for biologicals in India has grown in recent years due to several factors.

“The growth is a combination of long-term government support plus a strong agricultural extension/research network plus industry-led farmer education,” says Piyatida Pukclai, Regional Sales & Regulatory Policy Manager (Asia-Pacific) for knoell.

Pukclai and Lawrence Middler, Biologicals Senior Analyst at AgbioInvestor, dig into what’s accelerating interest.

Government Support

India is smallholder-driven market, with around 46% of the population involved in agriculture, and 18% of gross domestic product coming from agriculture.

Therefore, the influence that governmental support mechanisms and programs have on the adoption of biologicals cannot be understated, Middler says.

Top Articles
AgriBusiness Global on the Road: SICIT Group Dedicates New Plant in Leon, Mexico

Pukclai agrees.

“The Indian government has supported biological control and integrated pest management for many years through the Indian Council of Agricultural Research, its research program, and the nationwide Krishi Vigyan Kendra extension network,” Pukclai says.

Farmer training, field demonstrations, and awareness programs are also actively carried out by the Indian Council of Agricultural Research and other government bodies, Pukclai says.

Middler points to the Government of India’s Financing Agrochemical Reduction and Management program, which focuses on supporting the widespread transition toward safer and more sustainable agricultural practices by boosting farmer access to credit and providing robust training to growers on product usage across eight crops and 10 states within the country.

“Growers are provided with education across all aspects of the product use spectrum. This includes application methodologies, timing and dose rates, soil health, personal protection, optimal storage and disposal of containers, and integrated pest management strategies,” Middler says.

Other government initiatives to improve adoption include:

  • Capital Investment Subsidy Program
  • National Action Plan on Climate Change
  • National Mission for Sustainable Agriculture
  • National Program for Organic Production
  • Organic Farming Policy
  • Paramparagat Krishi Vikas Yojana
  • Sikkim Organic Mission
  • Soil Health Management
  • Strengthening and Modernizing Pest Management Approach in India
  • Zero Budget Natural Farming

Manufacturer Support

At the same time, manufacturers of biological products play an important role in adoption.

Pukclai and Middler point to biological companies providing demonstrations, technical support, and farmer education.

“Product support can quickly build up brand awareness and recognition, and it has been shown that growers are adept at spreading their knowledge to their extended farmer networks,” Middler says. “This is especially important in fragmented smallholder-centric markets such as India and elsewhere in South/Southeast Asia. Companies with more limited activities in support and outreach are likely to be at a disadvantage compared to others.”

Barriers to Adoption

Among the most significant factors that will limit adoption include constraints on grower incomes, Middler says.

While government subsidies can help, Middler notes that there needs to be a continued investment in lowering manufacturing costs to allow products to be sold at a lower price point while still allowing the manufacturer to achieve a good margin.

“This can be achieved through a number of means, including increasing the volume of manufacturing to capitalize on economies of scale, and also from utilizing the latest biotechnologies,” Middler says.

Over-regulation and bureaucracy can hamper investment, innovation, and product availability.

“Markets such as the EU have demonstrated that high regulatory barriers can detract from delivering the latest technologies, constrain market growth, and be antithetical to sustainability goals,” Middler says. “At the other end of the spectrum are markets such as Brazil, where regulatory processes are more streamlined. However, there can be a high level of substandard illicit products and on-farm production. Robust enforcement is important for the former, while steps have been taken to formalize the latter through the Bio-inputs Law.”

In an effort to overcome these barriers, Middler says India can emulate other countries like China, which outline longer-term agricultural and sustainability goals and set in motion national policy frameworks that work toward achieving them. Another example is Japan, which has a strong level of biologicals innovation stemming from the R&D-driven agrochemical companies and sustainability leadership.

Looking Ahead

Middler says future trajectory of the biopesticide industry in India will likely be determined by the wider dynamics within the crop protection industry.

“The market continues to benefit from increasing technification, including higher product usage intensity, increased adoption of seed treatment technology, trading up to more advanced product technologies, and the requirement to boost crop yields in order to feed a rising population,” Middler says.

He also expects climate volatility to act as a significant factor in the market as issues arising from severe drought stress, heat stress, and wind damage could severely impact production.

“Biostimulant products as an adjacent segment will likely benefit. However, crops damaged beyond a certain point of no return cannot simply be salvaged by using the latest biopesticide and biostimulant technologies,” Middler says. “This has the potential to limit grower incomes and subsequent investment in biological products in the next growing season.”

8.9%

This is the compound annual growth rate of the biopesticide market value in India per annum between 2020 and 2025, according to AgbioInvestor’s research.

AgbioInvestor’s estimates place India among the fastest-growing markets globally, but somewhat behind markets such as Brazil, where growth has been in the double-digit range for several years.

Bioinsecticides remain by far the most significant segment within India, but there is a growing level of company activity in biofungicide products. Bioherbicides lag behind significantly due to a technology gap for products that can offer multiple key attributes in a single product, such as a broad spectrum of control, crop selectivity, shelf life, and cost.

“As in the conventional chemical market, the biopesticide market is ultimately a solutions-based one,” Middler says. “Products that can demonstrate cost-effective control of critical pest species have a higher likelihood of achieving successful market reach.”